Lebedev, M.; Benjamin, A.B.; Kumar, S.; Molchanova, N.; Lin, J.S.; Koster, K.J.; Leibowitz, J.L.; Barron, A.E.; Cirillo, J.D.
Antiviral Effect of Antimicrobial Peptoid TM9 and Murine Model of Respiratory Coronavirus Infection. Pharmaceutics 2024, 16, 464.
https://doi.org/10.3390/pharmaceutics16040464
AMA Style
Lebedev M, Benjamin AB, Kumar S, Molchanova N, Lin JS, Koster KJ, Leibowitz JL, Barron AE, Cirillo JD.
Antiviral Effect of Antimicrobial Peptoid TM9 and Murine Model of Respiratory Coronavirus Infection. Pharmaceutics. 2024; 16(4):464.
https://doi.org/10.3390/pharmaceutics16040464
Chicago/Turabian Style
Lebedev, Maxim, Aaron B. Benjamin, Sathish Kumar, Natalia Molchanova, Jennifer S. Lin, Kent J. Koster, Julian L. Leibowitz, Annelise E. Barron, and Jeffrey D. Cirillo.
2024. "Antiviral Effect of Antimicrobial Peptoid TM9 and Murine Model of Respiratory Coronavirus Infection" Pharmaceutics 16, no. 4: 464.
https://doi.org/10.3390/pharmaceutics16040464
APA Style
Lebedev, M., Benjamin, A. B., Kumar, S., Molchanova, N., Lin, J. S., Koster, K. J., Leibowitz, J. L., Barron, A. E., & Cirillo, J. D.
(2024). Antiviral Effect of Antimicrobial Peptoid TM9 and Murine Model of Respiratory Coronavirus Infection. Pharmaceutics, 16(4), 464.
https://doi.org/10.3390/pharmaceutics16040464
